136 related articles for article (PubMed ID: 9358552)
1. Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.
Braun A; Alsenz J
Pharm Res; 1997 Oct; 14(10):1394-400. PubMed ID: 9358552
[TBL] [Abstract][Full Text] [Related]
2. Interferon immunogenicity: technical evaluation of interferon-alpha 2a.
Hochuli E
J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S15-21. PubMed ID: 9241611
[TBL] [Abstract][Full Text] [Related]
3. Long-term stabilization of a new freeze-dried and albumin-free formulation of recombinant human interferon alpha 2b.
Ruiz L; Reyes N; Sotolongo J; Aroche K; Aldana R; Báez R; Hardy E
PDA J Pharm Sci Technol; 2006; 60(1):72-8. PubMed ID: 17089680
[TBL] [Abstract][Full Text] [Related]
4. Elimination of the free sulfhydryl group in the human serum albumin (HSA) moiety of human interferon-alpha2b and HSA fusion protein increases its stability against mechanical and thermal stresses.
Zhao HL; Xue C; Wang Y; Sun B; Yao XQ; Liu ZM
Eur J Pharm Biopharm; 2009 Jun; 72(2):405-11. PubMed ID: 19462475
[TBL] [Abstract][Full Text] [Related]
5. Development of a high performance size exclusion chromatography method to determine the stability of Human Serum Albumin in a lyophilized formulation of Interferon alfa-2b.
Qian J; Tang Q; Cronin B; Markovich R; Rustum A
J Chromatogr A; 2008 Jun; 1194(1):48-56. PubMed ID: 18258245
[TBL] [Abstract][Full Text] [Related]
6. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice.
Braun A; Kwee L; Labow MA; Alsenz J
Pharm Res; 1997 Oct; 14(10):1472-8. PubMed ID: 9358564
[TBL] [Abstract][Full Text] [Related]
7. Circumventing the heterogeneity and instability of human serum albumin-interferon-alpha2b fusion protein by altering its orientation.
Zhao HL; Xue C; Wang Y; Li XY; Xiong XH; Yao XQ; Liu ZM
J Biotechnol; 2007 Sep; 131(3):245-52. PubMed ID: 17698234
[TBL] [Abstract][Full Text] [Related]
8. Long-term stabilization of recombinant human interferon alpha 2b in aqueous solution without serum albumin.
Ruiz L; Reyes N; Duany L; Franco A; Aroche K; Hardy Rando E
Int J Pharm; 2003 Oct; 264(1-2):57-72. PubMed ID: 12972336
[TBL] [Abstract][Full Text] [Related]
9. Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering.
Zhao HL; Yao XQ; Xue C; Wang Y; Xiong XH; Liu ZM
Protein Expr Purif; 2008 Sep; 61(1):73-7. PubMed ID: 18541441
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity of an enzyme immunoassay for human interferon alpha 1 using a mixture of three monoclonal antibodies.
Karayianni-Vasconcelos G; Mucha V; Kontsek P
J Immunoassay; 1994 Aug; 15(3):251-61. PubMed ID: 7929852
[TBL] [Abstract][Full Text] [Related]
11. Preparation and biological evaluation of a glycosylated fusion interferon directed to hepatic receptors.
Cai G; Jiang M; Zhang B; Zhou Y; Zhang L; Lei J; Gu X; Cao G; Jin J; Zhang R
Biol Pharm Bull; 2009 Mar; 32(3):440-3. PubMed ID: 19252292
[TBL] [Abstract][Full Text] [Related]
12. An enzyme-linked immunosorbent assay (ELISA) for quantitation of adducts of granulocyte-macrophage colony stimulating factor (GM-CSF) and human serum albumin (HSA) in stressed solution mixtures.
Kumarasamy R; Bausch J; Kopcha D; Patel S; McGonigle E
Pharm Res; 1994 Mar; 11(3):365-71. PubMed ID: 8008700
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antigenic properties of three interferon (IFN)-alpha 2 subvariants and establishement of a quantitative IFN-alpha 2 ELISA.
Karayianni-Vasconcelos G; Fuchsberger N; Skamlová Z; Kontsek P
Acta Virol; 1993 Dec; 37(6):509-14. PubMed ID: 8010188
[TBL] [Abstract][Full Text] [Related]
14. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycated human serum albumin as AGE-carrier protein in enzyme-linked immunosorbent assay.
Benko B; Turk Z
Clin Lab; 2008; 54(9-10):331-9. PubMed ID: 19097490
[TBL] [Abstract][Full Text] [Related]
16. In situ precipitation and vacuum drying of interferon alpha-2a: development of a single-step process for obtaining dry, stable protein formulation.
Kumar V; Sharma VK; Kalonia DS
Int J Pharm; 2009 Jan; 366(1-2):88-98. PubMed ID: 18824225
[TBL] [Abstract][Full Text] [Related]
17. A highly sensitive electrochemiluminescence immunoassay for interferon alfa-2b in human serum.
Obenauer-Kutner LJ; Jacobs SJ; Kolz K; Tobias LM; Bordens RW
J Immunol Methods; 1997 Aug; 206(1-2):25-33. PubMed ID: 9328565
[TBL] [Abstract][Full Text] [Related]
18. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
Garidel P; Pevestorf B; Bahrenburg S
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
[TBL] [Abstract][Full Text] [Related]
19. Influence of human serum albumin content in formulations on the bioequivalency of interferon alfa-2a given by subcutaneous injection in healthy male volunteers.
Zhi J; Teller SB; Satoh H; Koss-Twardy SG; Luke DR
J Clin Pharmacol; 1995 Mar; 35(3):281-4. PubMed ID: 7608317
[TBL] [Abstract][Full Text] [Related]
20. Development of a lyophilization formulation that preserves the biological activity of the platelet-inducing cytokine interleukin-11 at low concentrations.
Page C; Dawson P; Woollacott D; Thorpe R; Mire-Sluis A
J Pharm Pharmacol; 2000 Jan; 52(1):19-26. PubMed ID: 10716599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
